Illustration: Allie Carl/Axios
Kohlberg is acquiring Alcanza Clinical Research from Martis Capital for between $800 million and $850 million, Axios Pro has learned.
Why it matters: It's an attractive comp for the slate of sponsor-backed clinical site platforms waiting in the wings.
